ADCT · ADC Therapeutics SA Common Shares
View on chartInsiders & Stakes
| Redmile Group, LLC 10% Owner | ▼ Sell | Open Market | 10,265,297 Shares held | 4/2/2026 | View profile |
| Hans Peter Wild 10% Owner | ▼ Sell | Other | 9,788,944 Shares held | 5/15/2025 | View profile |
| Ameet Mallik Director | ▲ Buy | Grant | 2,121,769 Shares held | 6/30/2026 | View profile |
| Jose Carmona Chief Financial Officer | ▲ Buy | Grant | 938,076 Shares held | 6/30/2026 | View profile |
| Mohamed Zaki Chief Medical Officer | ▲ Buy | Grant | 896,317 Shares held | 6/30/2026 | View profile |
| Peter J. Graham Chief Legal Officer | ▲ Buy | Grant | 841,640 Shares held | 6/30/2026 | View profile |
| Peter Hug Director | ▼ Sell | Tax Withholding | 263,344 Shares held | 6/3/2026 | View profile |
| Viviane Monges Director | ▼ Sell | Tax Withholding | 186,447 Shares held | 6/3/2026 | View profile |
| Thomas Pfisterer Director | ▼ Sell | Other | 173,899 Shares held | 5/15/2025 | View profile |
| Victor Sandor Director | ▼ Sell | Tax Withholding | 140,686 Shares held | 6/3/2026 | View profile |
| Jean-Pierre Bizzari Director | ▼ Sell | Tax Withholding | 139,302 Shares held | 6/3/2026 | View profile |
| Lisa Michelle Kallebo Chief Accounting Officer | ▼ Sell | Tax Withholding | 128,224 Shares held | 2/13/2026 | View profile |
| Ron Squarer Director | ▼ Sell | Tax Withholding | 123,431 Shares held | 6/3/2026 | View profile |
| Robert Azelby Director | ▼ Sell | Tax Withholding | 112,805 Shares held | 6/3/2026 | View profile |
| Timothy Coughlin Director | ▼ Sell | Tax Withholding | 72,400 Shares held | 6/3/2026 | View profile |
Transaction History
| Ameet Mallik | ▲ Buy | Grant | 675,000 | $0 | 6/30/2026 |
| Peter J. Graham | ▲ Buy | Grant | 221,100 | $0 | 6/30/2026 |
| Mohamed Zaki | ▲ Buy | Grant | 213,900 | $0 | 6/30/2026 |
| Jose Carmona | ▲ Buy | Grant | 203,700 | $0 | 6/30/2026 |
| Robert Azelby | ▼ Sell | Tax Withholding | 12,600 | $39K | 6/3/2026 |
| Ron Squarer | ▼ Sell | Tax Withholding | 15,196 | $47K | 6/3/2026 |
| Victor Sandor | ▼ Sell | Tax Withholding | 12,600 | $39K | 6/3/2026 |
| Viviane Monges | ▼ Sell | Tax Withholding | 2,596 | $8K | 6/3/2026 |
| Peter Hug | ▼ Sell | Tax Withholding | 2,156 | $7K | 6/3/2026 |
| Jean-Pierre Bizzari | ▼ Sell | Tax Withholding | 12,600 | $39K | 6/3/2026 |
| Timothy Coughlin | ▼ Sell | Tax Withholding | 12,600 | $39K | 6/3/2026 |
| Robert Azelby | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Ron Squarer | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Victor Sandor | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Viviane Monges | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Peter Hug | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Jean-Pierre Bizzari | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Timothy Coughlin | ▲ Buy | Grant | 45,000 | $0 | 6/1/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 2,634,506 | $8.6M | 4/2/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 2,529,491 | $8.3M | 4/2/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 169,265 | $643K | 4/1/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 162,517 | $617K | 4/1/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 188,407 | $707K | 3/31/2026 |
| Redmile Group, LLC | ▼ Sell | Open Market | 196,229 | $736K | 3/31/2026 |
| Lisa Michelle Kallebo | ▲ Buy | Grant | 62,900 | $251K | 2/13/2026 |
| Lisa Michelle Kallebo | ▼ Sell | Tax Withholding | 5,433 | $22K | 2/13/2026 |
| Mohamed Zaki | ▲ Buy | Grant | 285,200 | $1.1M | 2/13/2026 |
| Mohamed Zaki | ▼ Sell | Tax Withholding | 24,603 | $98K | 2/13/2026 |
| Peter J. Graham | ▲ Buy | Grant | 294,800 | $1.2M | 2/13/2026 |
| Peter J. Graham | ▼ Sell | Tax Withholding | 33,294 | $133K | 2/13/2026 |
| Jose Carmona | ▲ Buy | Grant | 271,600 | $1.1M | 2/13/2026 |
| Jose Carmona | ▼ Sell | Tax Withholding | 25,880 | $103K | 2/13/2026 |
| Ameet Mallik | ▲ Buy | Grant | 900,000 | $3.6M | 2/13/2026 |
| Ameet Mallik | ▼ Sell | Tax Withholding | 103,231 | $412K | 2/13/2026 |
| Lisa Michelle Kallebo | ▼ Sell | Tax Withholding | 7,140 | $23K | 12/6/2025 |
| Peter J. Graham | ▼ Sell | Tax Withholding | 49,508 | $163K | 12/6/2025 |
| Jose Carmona | ▼ Sell | Tax Withholding | 53,236 | $175K | 12/6/2025 |
| Ameet Mallik | ▼ Sell | Tax Withholding | 233,146 | $767K | 12/6/2025 |
| Mohamed Zaki | ▼ Sell | Tax Withholding | 41,068 | $135K | 12/6/2025 |
| Ron Squarer | ▼ Sell | Tax Withholding | 15,184 | $54K | 6/13/2025 |
| Victor Sandor | ▼ Sell | Tax Withholding | 12,600 | $45K | 6/13/2025 |
| Jean-Pierre Bizzari | ▼ Sell | Tax Withholding | 12,600 | $45K | 6/13/2025 |
| Robert Azelby | ▼ Sell | Tax Withholding | 12,600 | $45K | 6/13/2025 |
| Viviane Monges | ▼ Sell | Tax Withholding | 2,584 | $9K | 6/13/2025 |
| Peter Hug | ▼ Sell | Tax Withholding | 2,144 | $8K | 6/13/2025 |
| Jean-Pierre Bizzari | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Robert Azelby | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Viviane Monges | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Peter Hug | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Victor Sandor | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Ron Squarer | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Timothy Coughlin | ▲ Buy | Grant | 40,000 | $0 | 6/3/2025 |
| Hans Peter Wild | ▼ Sell | Other | 9,788,944 | — | 5/15/2025 |
| Thomas Pfisterer | ▼ Sell | Other | 451,856 | — | 5/15/2025 |
| Ameet Mallik | ▼ Sell | Tax Withholding | 26,758 | $35K | 5/6/2025 |
| Ameet Mallik | ▲ Buy | Grant | 650,000 | $1.0M | 2/13/2025 |
| Peter J. Graham | ▲ Buy | Grant | 220,000 | $354K | 2/13/2025 |
| Mohamed Zaki | ▲ Buy | Grant | 230,000 | $370K | 2/13/2025 |
| Lisa Michelle Kallebo | ▲ Buy | Grant | 41,900 | $67K | 2/13/2025 |
| Jose Carmona | ▲ Buy | Grant | 240,000 | $386K | 2/13/2025 |
| Redmile Group, LLC | ▲ Buy | Open Market | 50,000 | $114K | 12/11/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 50,000 | $191K | 12/11/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 50,000 | $114K | 12/11/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 50,000 | $191K | 12/11/2024 |
| Mohamed Zaki | ▼ Sell | Tax Withholding | 37,112 | $116K | 12/6/2024 |
| Lisa Michelle Kallebo | ▼ Sell | Tax Withholding | 6,503 | $20K | 12/6/2024 |
| Jose Carmona | ▼ Sell | Tax Withholding | 48,108 | $151K | 12/6/2024 |
| Peter J. Graham | ▼ Sell | Tax Withholding | 41,458 | $130K | 12/6/2024 |
| Ameet Mallik | ▼ Sell | Tax Withholding | 238,343 | $746K | 12/6/2024 |
| Redmile Group, LLC | ▼ Sell | Open Market | 25,352 | $52K | 12/4/2024 |
| Redmile Group, LLC | ▼ Sell | Other | 50,672 | $105K | 12/4/2024 |
| Redmile Group, LLC | ▼ Sell | Other | 50,672 | $105K | 12/4/2024 |
| Redmile Group, LLC | ▼ Sell | Other | 50,672 | $105K | 12/4/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 400,000 | $1.1M | 7/1/2024 |
| Redmile Group, LLC | ▲ Buy | Open Market | 400,000 | $1.1M | 7/1/2024 |
| Ron Squarer | ▼ Sell | Open Market | 6,995 | $20K | 6/17/2024 |
| Robert Azelby | ▼ Sell | Open Market | 6,995 | $20K | 6/17/2024 |
| Jean-Pierre Bizzari | ▼ Sell | Open Market | 6,995 | $20K | 6/17/2024 |
| Peter Hug | ▼ Sell | Open Market | 1,193 | $3K | 6/17/2024 |
| Viviane Monges | ▼ Sell | Open Market | 1,437 | $4K | 6/17/2024 |
| Thomas Pfisterer | ▼ Sell | Open Market | 1,437 | $4K | 6/17/2024 |
| Victor Sandor | ▼ Sell | Open Market | 6,995 | $20K | 6/17/2024 |
| Robert Azelby | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Jean-Pierre Bizzari | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Peter Hug | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Thomas Pfisterer | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Victor Sandor | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Ron Squarer | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Viviane Monges | ▲ Buy | Grant | 40,000 | $0 | 6/13/2024 |
| Ameet Mallik | ▼ Sell | Open Market | 29,731 | $133K | 5/7/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ADC Therapeutics Announces $86.6M Financing and Loan Amendments
ADC Therapeutics has secured $86.6 million through a private placement of 12.9 million shares at $1.42 each, along with warrants for 48.1 million shares. The company also amended its existing loan and royalty agreements. This capital raise provides additional liquidity to support operations, occurring while the stock trades near the top of its recent range.
ADC Therapeutics Announces $86.6M Financing and Loan Amendments. ADC Therapeutics has secured $86.6 million through a private placement of 12.9 million shares at $1.42 each, along with warrants for 48.1 million shares. The company also amended its existing loan and royalty agreements. This capital raise provides additional liquidity to support operations, occurring while the stock trades near the top of its recent range.